The governance
Board of directors
The IHU is steered by a board of directors (CA) which defines its general policy.
It is made up of 16 members, 6 founding members, 5 qualified personalities, 3 representatives from the economic world and 2 representatives elected by teacher-researchers. The CA is chaired by Mr. Thierry Tuot, State Councillor.
Thierry Tuot
Chairman of the board
“Like all start-ups, ICAN has been able to cast doubt on the viability of its future. The retrospective view that this report now allows us to cast on its growth shows that the future of our IHU is now firmly assured and that its project is being deployed vigorously. These last two years have been those of normalization, of a management that has become rigorous, transparent and efficient; consolidation, by refocusing the institute’s project on its fundamentals; investment, through the acquisition of the unique research MRI which is the key asset of our action; of integration, ICAN having alongside its founders, in close collaboration at all times with them, found its way, its specificity, and the path to its added value. Despite the health crisis (to the resolution of which it contributes for the future) the IHU has remained mobilized, active; he demonstrated that his project was valid and found, in France, in Europe, reliable partners, with whom he writes, as a recognized major player, an essential page of medical research. It owes its success to the unwavering support, which is not a gamble, but a rational choice for the future, of its founding members, Sorbonne University, AP-HP and INSERM. It owes its success first and foremost to its teams, ardent, united, mobilized, professional and imaginative, whose creativity and rigor make the power of the tool they have built. Alongside them, the Board of Directors will continue to support and promote an action whose value will be demonstrated even more in the years to come. »
Representatives of the founders
Martin HIRSCH
Managing Director AP-HP
Gilles Bloch
Chairman and CEO INSERM
Nathalie DRACH-TEMAM
President Sorbonne University
Stephanie DECOOPMAN
AP - HP Clinical Research and Innovation Department / Acting Deputy Director AP- HP
Elli CHATZOPOULOU
Director of the Department of Partnerships and External Relations INSERM
Bruno RIOU
Dean of the Faculty of Medicine
Qualified personalities
Catherine Boileau
AP-HP - PUPH
Claudine CANALE
President of “Les Poids Plume France”
Jessica LEGUES
CEO MEDICEN, Paris Region
Stanislav DUSKO EHRLICH
Research Director, INRIA
Representatives of the economic world
Laurence COMTE ARASSUS
GE Healthcare, General Manager, FBFA zone, Representative of SNITEM
Pierre SONIGO
SEBIA, Chief Scientist
Representatives of researchers, teacher-researchers
Corinne FRERE
MCU-PH, Biological Hematology, AP-HP
Bruno FEVE
CRSA, UMR-S 938
The executive committee
The Executive Committee (COMEX) of the IHU is made up of the Director General, the Secretary General, the heads of the IHU’s internal poles and one community representative per strategic axis. The director of the Pitié-Salpêtrière Hospital Group and the medical director of the DMU are permanent guests. The COMEX is responsible for assisting the Director General, particularly in defining the IHU’s strategy and scientific orientations, but also in all aspects of management.
The Chief Executive Officer is appointed for 4 years by the Chairman of the Board of Directors, from among the candidates proposed by the Board. The Director General is responsible for the general management of the IHU. He is assisted by a Secretary General in charge of the operational management of the Institute.
Dr. Judith ARON-WISNEWSKY
Endocrinology and metabolism
Dr Olivier BOURRON
Endocrinology and metabolism
Loic CARBADILLO
Director of Research, Innovation and Rare Diseases AP-HP Sorbonne University
Prof. Philippe CHARRON
Head of the Genomics and Pathophysiology of Myocardial Diseases Research Team UMR 1166 and Director of the Reference Center for Cardiomyopathies and Hereditary Heart Rhythm Disorders
Prof. Alain COMBES
Intensive medicine-resuscitation
Dr Laurie DUFOUR
Cardiology and vascular diseases
Pr. Bruno FEVE
Director of research unit 938 - Saint-Antoine research center
Dr Antonio GALLO
Endocrinology and metabolism
Prof. Estelle GANDJBAKHCH
Cardiology and vascular diseases
Prof. Richard ISNARD
Cardiology and vascular diseases
Dr Wilfried LE GOFF
Team leader, Systemic and cellular lipid metabolism in cardiometabolic diseases (UMR_S1166)
Philippe LESNIK
Biology of atherosclerosis
Prof. Irene NETCHINE
Physiology - Pediatric functional explorations
Prof. Vlad RATZIU
Gastroenterology and hepatology
Prof. Alban REDHEUIL
Cardiovascular imaging
The council of the IHU
The IHU board is made up of the general director of the IHU, the general secretary, the dean of the Sorbonne University faculty of medicine, the directors and team leaders of the UMRs involved in the ICAN, the medical director of the DMU Archimede, department heads of this DMU involved in the clinical activities of ICAN. The Chairman of the IHU Council is the Chief Executive Officer of the IHU. Its objective is to strengthen the internal cohesion of the medical and scientific community of the IHU and to allow a fluidity of information between the teams to ensure overall consistency. The purpose of the IHU council is to allow discussion and sharing on the strategic orientations and scientific policy of the IHU.
Prof. Zahir AMOURA
Head of the internal medicine department of the Pitié-Salpêtrière hospital
Elise BALSE
Head of the Molecular and Cellular Plasticity in Cardiovascular Diseases team – UMR 1166
Prof. Eric BRUCKERT
Head of the Department of Endocrinology, Metabolism and Prevention of Cardiovascular Diseases
Prof. Philippe CHARRON
Head of the Genomics and Pathophysiology of Myocardial Diseases Research Team UMR 1166 and Director of the Reference Center for Cardiomyopathies and Hereditary Heart Rhythm Disorders
Prof. Laurent CHICHÉ
Head of the Cardiovascular Surgery Department at Saint Antoine Hospital
Prof. Sophie CHRISTIN-MAITRE
Head of the Endocrinology, Diabetology and Reproductive Medicine Department at Saint-Antoine Hospital
Prof. Karine CLEMENT
Head of UMR 1269 Nutriomics - Nutrition and obesity
Prof. Ariel COHEN
Head of the Cardiology Department at Saint Antoine Hospital
Prof. Jean-Philippe COLLET
Head of Interventional Cardiology Unit of the GH PSL Cardiology Institute, Head of Team 2 Atherothrombosis and Applied Pharmacology - UMR 1166
Prof. Alain Combès
Head of the resuscitation department at the Pitié-Salpêtrière hospital
Prof. Bruno FEVE
Director of research unit 938 – Saint-Antoine research center
Fabienne FOUFELLE
Head of the metabolic diseases, diabetes and comorbidities team – UMR 1138 Cordeliers research center
Prof. Christian FUNCK-BRENTANO
Head of the Paris-Est Clinical Investigation Center (CIC)
Prof. Agnes HARTEMANN
Head of the diabetology department at IE3M
Prof. Chantal HOUSSET
Head of the team Fibroinflammatory diseases of metabolic and biliary origin of the liver - Research unit 938 – Saint-Antoine research center
Prof. Richard ISNARD
HEAD OF DMU ARCHIMEDE
Nadjia KACHENOURA
Cardiovascular imaging team leader UMR 1146
Wilfried LE GOFF
Team leader Cellular lipid metabolism in cardiovascular diseases – UMR 1166
Prof. Laurence LEENHARDT
Head of the Functional Unit for Thyroid and Endocrine Tumor Pathologies
Prof. Pascal LEPRINCE
Head of the Department of Cardiac Surgery at the Heart Institute of the Pitié-Salpêtrière Hospital Group
Philippe LESNIK
Head of the Mononuclear phagocytes in metabolic diseases team – UMR116
Prof. Gilles MONTALESCOT
Head of the Cardiology Department of the Heart Institute of the Pitié Salpêtrière Hospital Group
Sophie NADAUD
Head of the Molecular and Cellular Plasticity in Cardiovascular Diseases team – UMR 1166
Prof. Irene NETCHINE
Head of the IGF system, fetal and postnatal growth team - Research unit 938 - Saint-Antoine research center
Prof. Michael OPPERT
Head of the nutrition department of the E3M institute and the human nutrition research center (CRNH)
Prof. Christine POITOU-BERNERT
Nutrition - Genetic Rare Obesity Reference Center
Prof. Alban REDHEUIL
Head of Cardiovascular Imaging Unit of the Heart Institute of the Pitié-Salpêtrière Hospital Group
Prof. Bruno RIOU
Dean of the Faculty of Medicine
Prof. Philippe TOURAINE
Head of Endocrinology and Reproductive Medicine
Prof. Corinne VIGOUROUX
Reference center for rare pathologies of insulin-secretion and insulin-sensitivity (PRISIS)
The scientific council
The scientific council of ICAN is composed of 6 external personalities, highly recognized by the international scientific community, in the field of cardiometabolism and nutrition. This scientific governance body, appointed by the Board of Directors, is consulted on the main scientific orientations and the annual action program of the IHU. The scientific council also evaluates the scientific performance of the Foundation. He is very involved in the scientific life of ICAN and plays a fundamental role in it.
Prof. Rozemarijn VLIEGENTHART
Radiologist and Professor of Cardiothoracic Imaging
Groningen University Medical Center
Netherlands
Prof. Michael RODEN
Professor of Endocrinology and Metabolic Diseases
Düsseldorf University Hospital
Germany
Prof. Karin SIPIDO
Professor of Medicine and Head of Experimental Cardiology
University of Leuven
Belgium
Prof. André CARPENTIER
Director of the “Diabetes, obesity and cardiovascular complications” research axis
Faculty of Medicine and Health Sciences of the University of Sherbrooke
Canada
Prof. Arnold VON ECKARDSTEIN
Clinical Biochemistry, Laboratory Medicine and Pathology
University Center for Laboratory Medicine and Pathology (UZL)
Swiss
Prof. Lesley HOYLES
Professor of Microbiome and Systems Biology
Nottingham Trent University
United Kingdom
Professor Rozemarijn Vliegenthart
Groningen University Medical Center - Netherlands
“ICAN is a unique research institute due to its multidisciplinary approach to a central and complex morbidity problem, cardiometabolic diseases, and broad research scope, from basic research to implementation, using state-of-the-art techniques.
A particular strength of this world-wide leading institute is the involvement of experts from different fields, including clinic, -omics and imaging, in research projects, leading to new insights on pathophysiology, biomarkers and potential targets for treatment or response evaluation.
Importantly, ICAN has a central focus on the patient, patient journey, and prevention. Lastly, I think a key component that helps to anchor the research findings and techniques is the ICAN education and teaching program for future colleagues in research and clinic. »
